198 集

As the number of Americans living with diabetes continues to rise, staying up to date on the latest diabetes research is more essential than ever to help patients achieve glucose control. With Diabetes Discourse, you’ll hear from diabetes and endocrinology experts on emerging research, diagnostic and treatment strategies, and various elements that impact a patient’s disease course, including risk factors, vitamin and mineral supplementation, physical activity, and kidney disease.
Because when it comes to diabetes, glucose control is just the beginning.

Diabetes Discourse ReachMD

    • 科学
    • 5.0 • 1 个评分

As the number of Americans living with diabetes continues to rise, staying up to date on the latest diabetes research is more essential than ever to help patients achieve glucose control. With Diabetes Discourse, you’ll hear from diabetes and endocrinology experts on emerging research, diagnostic and treatment strategies, and various elements that impact a patient’s disease course, including risk factors, vitamin and mineral supplementation, physical activity, and kidney disease.
Because when it comes to diabetes, glucose control is just the beginning.

    Overcoming Obesity: Insights from the SURMOUNT-4 Trial

    Overcoming Obesity: Insights from the SURMOUNT-4 Trial

    Host: John Buse, MD, PhD

    Guest: Louis J. Aronne, MD, FTOS



    In the SURMOUNT-4 trial, 100 patients with obesity were on tirezpatide for 9 months, and the average weight loss was 20.9 percent. The patients were then randomized to receive either placebo with behavioral intervention or tirzepatide for another year, and the patients in the former group regained a significant amount of weight. Dive further into the study’s findings and implications with Dr. John Buse and Dr. Louis Aronne, the Sanford I. Weill Professor of Metabolic Research at Weill Cornell Medical College in New York.

    Strategies for Addressing Diabetes Stigma and Discrimination

    Strategies for Addressing Diabetes Stigma and Discrimination

    Host: John Buse, MD, PhD

    Guest: Mary de Groot, PhD



    The prevalence of diabetes-related stigma is alarmingly high. In fact, four in five adults have reported experiencing some form of diabetes stigma at some point in their lives. To learn how we as healthcare providers can help reduce this burden for our patients with diabetes, Dr. John Buse speaks with Dr. Mary de Groot, Professor of Medicine and the Associate Vice Chair for Wellness at Indiana University School of Medicine.

    How the Artificial Pancreas Can Help Diabetic Patients

    How the Artificial Pancreas Can Help Diabetic Patients

    Host: Stuart Weinzimer, MD



    The artificial pancreas represents the integration of two separate devices: a continuous glucose monitor and an insulin pump. Learn more about this technology and how it can help improve diabetic patients’ quality of life with Dr. Stuart Weinzimer, Interim Section Chief of Pediatric Endocrinology and Diabetes at Yale School of Medicine.

    Using CGMs and Insulin Pumps to Treat Pediatric Patients with T1D

    Using CGMs and Insulin Pumps to Treat Pediatric Patients with T1D

    Host: Stuart Weinzimer, MD



    From continuous glocuose monitors to insulin pumps, there have been immense technological advancements for patients with type 1 diabetes. Learn more about how these two tools can be used to treat pediatric patients with type 1 diabetes with Dr. Stuart Weinzimer, Interim Section Chief of Pediatric Endocrinology and Diabetes at Yale School of Medicine.

    Challenging the Misconception That T1D Is a Childhood-Onset Disease

    Challenging the Misconception That T1D Is a Childhood-Onset Disease

    Host: John Buse, MD, PhD

    Guest: Michael Fang, PhD



    According to a recent study published in the Annals of Internal Medicine, the median age of patients with type 1 diabetes is 24. However, type 1 diabetes that develops in adulthood is often mistakenly identified as type 2 diabetes, resulting in improper treatment. Joining Dr. John Buse to review this study’s key findings and how we can determine if an adult with new-onset diabetes might have type 1 diabetes is Dr. Michael Fang, Assistant Professor in the Division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University.

    Decoding Diabetes Diversity: A Study on Heterogeneity and Endotypes in T1D

    Decoding Diabetes Diversity: A Study on Heterogeneity and Endotypes in T1D

    Host: John Buse, MD, PhD

    Guest: Maria Jose Redondo, MD, PhD, MPH



    A recent paper focused on a variety of topics associated with type 1 diabetes, including its heterogenenity, endotypes, slowly progressive insulin-dependent diabetes, and the term type 1.5 diabetes. Dive into these topics with Dr. John Buse and Dr. Maria Redondo, Professor of Pediatrics in the Division of Pediatric Diabetes and Endocrinology at Baylor College of Medicine in Texas.

用户评论

5.0(满分 5 分)
1 个评分

1 个评分